This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Express Scripts (ESRX) Q3 Earnings In Line, FY17 View Up
by Zacks Equity Research
Express Scripts Holding Company (ESRX) posted robust first-quarter numbers driven by operational cost improvement backed by focus on technology, digital tools, home delivery and specialty services.
Intuitive Surgical (ISRG) Beats on Q3 Earnings & Revenues
by Zacks Equity Research
Intuitive Surgical (ISRG) posted solid numbers in the third quarter, courtesy of rising customer adoption of procedures and growth in system placements.
athenahealth (ATHN) Beats Earnings, Misses Revenues in Q3
by Zacks Equity Research
athenahealth (ATHN) witnessed a year-over-year increase in Q3 revenues on the back of strength in its Business and Services segment.
The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, SeaSpine Holdings and EnteroMedics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, SeaSpine Holdings and EnteroMedics
4 Momentum Stocks That May Survive the Health Policy Mess
by Zacks Equity Research
In view of the current political scenario and banking on favorable metrics, these four MedTech stocks stand out as the most suitable momentum picks.
Weakness Seen in Glaukos (GKOS) Estimates: Should You Stay Away?
by Zacks Equity Research
Glaukos (GKOS) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
ABIOMED (ABMD) Banks on Impella Platform, Forex a Concern
by Zacks Equity Research
ABIOMED (ABMD) is focusing heavily in its proprietary Impella Platform to enhance customer base.
Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength
by Zacks Equity Research
Luminex Corp (LMNX) is focusing on augmenting its portfolio strength through new FDA approvals.
Who Says Rising P/E Is Risky? 5 Top Stocks That Deny
by Zacks Equity Research
Cross the age-old barrier of low P/E investing, bet on these five stocks that boast a rising P/E.
Community Health System Divests Hospitals to Lower Debts
by Zacks Equity Research
Community Health Systems, Inc. (CYH) resorts to divestitures in order to finance its long-term debts.
Here's Why EnteroMedics (ETRM) Stock Soared Today
by Ryan McQueeney
Shares of EnteroMedics (ETRM) were up more than 10% in morning trading Tuesday after it was confirmed that the medical device company's new neuro-blocking obesity treatment will be featured on the daytime talk show The Doctors.
Stock Market Roundup, Jan. 10: NVDA Self-Driving Cars, ETRM Soars
by Ryan McQueeney
Stocks continued their relatively solid start to the New Year with another positive day of trading on Tuesday. Perhaps the biggest newsmakers on the day were NVIDIA and Mercedes-Benz, as the pair announced a partnership to produce self-driving cars.